LawrenceScottBlaszkowskyMD

Oncology • Newton, MA

Instructor in Medicine, Massachusetts General Hospital

Join to view full profile

Dr. Blaszkowsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blaszkowsky's full profile

Already have an account?

Office
2014 Washington Street
Hematology/Oncology
Newton, MA 02462
Phone+1 617-219-1230

Fax+1 617-831-7350

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1990 - 1993
SUNY Upstate Medical UniversityClass of 1990

Certifications & Licensure

MA State Medical License 1995 - 2026
NY State Medical License 1991 - 1996
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer Start of enrollment: 2006 May 01
Terminated
Phase 1, Phase 2
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer Start of enrollment: 2006 May 01
Completed
Phase 1, Phase 2
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer Start of enrollment: 2006 Aug 01
Completed
Phase 2
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas Start of enrollment: 2009 Aug 01
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of 2 Prospective Trials.
Grace Lee, Bailey Nelson, Julie Koenig, John P Plastaras, James M Metz
International Journal of Radiation Oncology, Biology, Physics. 2025-01-10
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.
Ryan J Park, Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S Kulkarni
Medrxiv. 2024-10-08
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Grace Lee, Daniel W Kim, Alicia C Smart, Nora K Horick, Christine E Eyler
American Journal of Clinical Oncology. 2024-08-01

Press Mentions

Folfox+Irinotecan+Chemort in Esophageal CancerDecember 7th, 2020
Losartan and Nivolumab in Combination with FOLFIRINOX and SBRT in Localized Pancreatic CancerJune 20th, 2018
Newton-Wellesley Hospital Expands Partnership with Mass General Cancer CenterMarch 15th, 2018

Professional Memberships

American Society of Clinical Oncology - ASCO
Member